2021 Abstract Submission

Abstract Submissions Are Now Closed!

Those that submitted an abstract should hear about their status by 1/22/21. 

Abstract submission will be limited to trainees/post-doctoral fellows or young investigators within 3 years of completing their post-doctoral fellowship. During the application process, you will be asked to provide contact information for the Program Director to confirm your status in the program. All accepted abstract submitters will have the opportunity to record a presentation of their abstract and interact with meeting attendees. More information will follow after abstracts are reviewed. 


Abstract Categories:

  • End Points 
  • Immune Monitoring
  • Care Delivery
  • Novel Immunosuppressive Agents 
  • Other